ArticleEuropean journal of rheumatology2017

Rapid loss of efficacy of biosimilar infliximab in three patients with Behçet's disease after switching from infliximab originator.

Fabrizio Cantini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.